Toxicologists are scientific experts who study the harmful effects of chemicals, substances, and environmental agents on living organisms. Their work is essential in assessing the safety of pharmaceuticals, food additives, industrial chemicals, and cosmetics before these products reach the public. By conducting laboratory experiments, animal studies, and cellular assays, toxicologists determine safe exposure levels and identify potential health risks. They play a critical role in drug development by helping to evaluate toxicity profiles and ensure that new treatments meet safety regulations. Their insights also inform regulatory guidelines and public health policies that protect people from environmental hazards.
Toxicologists are often involved in forensic investigations, environmental assessments, and risk analysis. They collaborate with healthcare professionals, regulatory agencies, and environmental scientists to interpret data and recommend actions in cases of contamination, poisoning, or chemical exposure. Their expertise is particularly valuable in addressing concerns related to pollution, occupational safety, and the long-term health effects of chronic exposure to various substances. With advancements in analytical technology and molecular toxicology, toxicologists can now better understand how toxins interact with genes and cellular processes. Their work forms the foundation for ensuring public safety in an increasingly chemical-dependent world. As new chemicals are introduced into our environment, toxicologists remain essential in safeguarding health and maintaining ecological balance.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States